Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-CSVTCG-OH
3D-Ansicht

Biosynth logo

H-CSVTCG-OH

Ref. 3D-PP44258

1mg
189,00 €
10mg
195,00 €
100mg
349,00 €
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 27. Dezember 2024

Produktinformation

Name:
H-CSVTCG-OH
Synonyme:
  • NH2-Cys-Ser-Val-Thr-Cys-Gly-OH
Beschreibung:

Peptide H-CSVTCG-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CSVTCG-OH include the following: Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism ZS Chen, J Pohl , TJ Lawley, RA Swerlick - Journal of investigative , 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022202X15424303 Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36 WX Li, RJ Howard , LL Leung - Journal of Biological Chemistry, 1993 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)85403-0/abstract Structure and Function of Thrombospondins W Frazier - Trends in Glycoscience and Glycotechnology, 1992 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/tigg1989/4/16/4_16_152/_article/-char/ja/ The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 T Wakiyama, T Shinohara, T Shirakusa - Histology and , 2001 - hh.um.eshttps://www.hh.um.es/pdf/Vol_16/16_2/The%20localization%20of%20thrombospondin-1.pdf a Motif Shared by the Malaria Circumsporozoite Protein and Thrombospondin is Mediated Exclusively by its Glycosaminoglycan-Binding Region and Not by CSVTCG SM Gantt , P Clavijo, X Baic, J Esko - may be from any type of , 2000 - search.proquest.comhttps://search.proquest.com/openview/62ac16a7ea361a737bcf29c2fb6e2573/1.pdf?pq-origsite=gscholar&cbl=18750&diss=y#page=58 adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG SM Gantt , P Clavijo, X Bai, JD Esko, P Sinnis - Journal of Biological , 1997 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)38944-0/abstract Plasmodium falciparum-infected erythrocyte adhesion to the type 3 repeat domain of thrombospondin-1 is mediated by a modified band 3 protein S Eda, J Lawler , IW Sherman - Molecular and biochemical parasitology, 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166685199000584 A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of S Chatterjee, M Wery, P Sharma - Infection and , 1995 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.63.11.4375-4381.1995 Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1 R Simantov , M Febbraio , R Crombie - The Journal of , 2001 - Am Soc Clin Investighttps://www.jci.org/articles/view/9061 Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1 P CLEZARDIN , J LAWLER , J AMIRAL - Biochemical , 1997 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/321/3/819/34171 Heparin-and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. N Guo, HC Krutzsch, E Negre, T Vogel - Proceedings of the , 1992 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.89.7.3040 Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1. MD Kosfeld, WA Frazier - Journal of Biological Chemistry, 1992 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021925818419904 Cell attachment activity of the carboxyl-terminal domain of human thrombospondin expressed in Escherichia coli. MD Kosfeld, TV Pavlopoulos, WA Frazier - Journal of Biological Chemistry, 1991 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021925818542228 THE 1998 MOYER AWARD Characteristics of Thrombospondin-1 and Its Cysteine-Serine-Valine-Threonine-Cysteine-Glycine Receptor in Burn Wounds JJ Roth, WB Hughes, FA DeClement - Journal of Burn Care , 1998 - academic.oup.comhttps://academic.oup.com/jbcr/article-abstract/19/6/487/4757981 Localization of thrombospondin-1 and its cysteine-serine-valine-threonine-cysteine-glycine receptor in colonic anastomotic healing tissue JJ Roth, MA Buckmire, RH Rolandelli - Histology and , 1998 - hh.um.eshttps://www.hh.um.es/pdf/Vol_13/13_4/Localization%20of%20thrombospondin-l%20and%20its%20cysteine-serine-valine-threonine-cysteine-glycine%20recept.pdf Thrombospondin 1 and its specific cysteine-serine-valine-threonine-cysteine-glycine receptor in fetal wounds JJ Roth, JJ Sung, MS Granick , MP Solomon - Annals of plastic , 1999 - journals.lww.comhttps://journals.lww.com/annalsplasticsurgery/abstract/1999/05000/Thrombospondin_1_and_Its_Specific.16.aspx A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro JA Carron, SC Wagstaff, JA Gallagher - and biophysical research , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X00925749 Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin-1 J Zhou, VL Rothman, I Sargiannidou - Journal of cellular , 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.20076 Cloning and characterization of CSVTCG-specific receptor of thrombospondin-1 J Zhou - 2002 - search.proquest.comhttps://search.proquest.com/openview/4936bad0f3ba407c917959e11d28a4ba/1?pq-origsite=gscholar&cbl=18750&diss=y Thrombin-stimulated calcium mobilization is inhibited by thrombospondin via CD36 J Enenstein, K Gupta, GM Vercellotti - Experimental cell research, 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014482797938635 The Functional Significance of the CSVTCG-Specific Receptor in Breast Carcinoma Progression I Sargiannidou , G Tuszynski - 2002., 2002 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA405490 Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain. GP Tuszynski, VL Rothman, M Papale - The Journal of cell , 1993 - rupress.orghttps://rupress.org/jcb/article-abstract/120/2/513/14638 Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins. GP Tuszynski, VL Rothman, AH Deutch - The Journal of cell , 1992 - rupress.orghttps://rupress.org/jcb/article-abstract/116/1/209/14270 Stimulation of platelet activation and aggregation by a carboxyl-terminal peptide from thrombospondin binding to the integrin-associated protein receptor DJ Dorahy, RF Thorne, JV Fecondo - Journal of Biological , 1997 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)77610-8/abstract Angiocidin inhibitory peptides decrease tumor burden in a murine colon cancer model C Liebig, N Agarwal, GE Ayala , G Verstovsek - Journal of Surgical , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022480407001163 77: Inhibition of angiocidin by two novel peptides decreases tumor burden in an orthotopic nude mouse model C Liebig, N Agarwal, G Ayala - Journal of , 2007 - journalofsurgicalresearch.comhttps://www.journalofsurgicalresearch.com/article/S0022-4804(06)00707-4/abstract Inhibition of Angiogenesis by the First Type I Repeat Peptides of Thrombospondin-1 BI Yoo, GB Jeong - Korean Journal of Physical Anthropology, 2015 - e-aba.orghttps://e-aba.org/DOIx.php?id=10.11637/kjpa.2015.28.4.223 Thrombospondins as anti-angiogenic therapeutic agents B Vailh, JJ Feige - Current pharmaceutical design, 2003 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2003/00000009/00000007/art00008 Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N B Catimel, L Leung , H El Ghissasi, N Mercier - Biochemical , 1992 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/284/1/231/37093 Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding AS Asch, S Silbiger, E Heimer, RL Nachman - Biochemical and biophysical , 1992 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0006291X9291860S INTERACTIONS OF THROMBOSPONDIN WITH CELLS A PART - Thrombospondin, 1993 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=Hanf7fhm_tsC&oi=fnd&pg=PA91&dq=(%22H-CSVTCG-OH%22+OR+%22CSVTCG%22+OR+%22NH2-Cys-Ser-Val-Thr-Cys-Gly-OH%22)+AND+peptide&ots=5QKzsRxT-P&sig=rdbLm8_Kg3vhMNQEczanw_NjVTI

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP44258 H-CSVTCG-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.